Geron (GERN) EBITDA Margin Growth (1y) (2011 - 2026)
Geron (GERN) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Geron |
729,618.77 |
729,618.77 |
- |
4,248.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
4,248.00 |
| Dec 31, 2025 |
6,912.00 |
| Sep 30, 2025 |
7,040.00 |
| Jun 30, 2025 |
783,549.00 |
| Mar 31, 2025 |
1.84 Mn |
| Dec 31, 2024 |
-2.54 Mn |
| Sep 30, 2024 |
2.89 Mn |
| Jun 30, 2024 |
17.13 Mn |
| Mar 31, 2024 |
17.24 Mn |
| Dec 31, 2023 |
1.69 Mn |
| Sep 30, 2023 |
-1.56 Mn |
| Jun 30, 2023 |
-14.08 Mn |
| Mar 31, 2023 |
-16.76 Mn |
| Dec 31, 2022 |
1.15 Mn |
| Sep 30, 2022 |
1.01 Mn |
| Jun 30, 2022 |
-1.13 Mn |
| Mar 31, 2022 |
-254,367.00 |
| Dec 31, 2021 |
4.36 Mn |
| Sep 30, 2021 |
-502,172.00 |
| Jun 30, 2021 |
1.20 Mn |
